Title
Newer lipid markers: Apolipoprotein B, LDL particle concentration, and triglyceride-rich lipoproteins - When are they needed?
Date Issued
01 January 2016
Access level
metadata only access
Resource Type
book part
Author(s)
Martin S.
Jones S.
Centro Johns Hopkins Ciccarone para la Prevención de las Enfermedades Cardiovasculares
Publisher(s)
Springer International Publishing
Abstract
Lowering low-density lipoprotein cholesterol (LDL-C) is a wellestablished strategy for cardiovascular risk reduction. Inherently, the focus is on LDL’s cholesterol content rather than its particle concentration. However, a number of studies have demonstrated that measures of particles burden, such as apolipoprotein B (apoB) and LDL particle concentration (LDL-P) can be discordant with LDL-C. When discordant, they appear to more strongly predict cardiovascular events, compared with LDL-C. Triglyceride-rich lipoproteins (TRL) play a key role in generating small dense LDL particles and are now causally implicated in atherosclerosis. This book chapter reviews the most important information about TRL, apoB, and LDL-P, and discusses relevant scenarios for the clinician where discordance between lipoprotein cholesterol content and lipoprotein particle concentration measurements should be considered.
Start page
145
End page
158
Language
English
OCDE Knowledge area
Sistema cardiaco, Sistema cardiovascular Fisiología
Scopus EID
2-s2.0-85009678181
Resource of which it is part
Cardiac Biomarkers: Case Studies and Clinical Correlations
ISBN of the container
9783319429823
Sources of information: Directorio de Producción Científica Scopus